XenaCare Holdings Announces National Print Advertising Campaign For Cobroxin, A Treatment For Moderate To Severe (Stage 2) Pain

XenaCare Holdings, Inc. (OTCBB: XCHO), a company specializing in the marketing and retail distribution of consumer healthcare products, has announced today that it will begin its national print advertising campaign for Cobroxin in November.